Final 3‐year clinical outcomes following transcatheter aortic valve implantation with a supra‐annular self‐expanding repositionable valve in a real‐world setting: Results from the multicenter FORWARD study

OBJECTIVES: The Evolut R FORWARD study confirmed safety and effectivenesss of the Evolut R THV in routine clinical practice out to 1 year. Herein, we report the final 3‐year clinical follow up of the FORWARD study. BACKGROUND: Transcatheter aortic valve replacement (TAVR) is a proven alternative to...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Mieghem, Nicolas M., Windecker, Stephan, Manoharan, Ganesh, Bosmans, Johan, Bleiziffer, Sabine, Modine, Thomas, Linke, Axel, Scholtz, Werner, Tchétché, Didier, Finkelstein, Ariel, Ito, Saki, Eisenberg, Ruth, Grube, Eberhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Valvular and Structural Heart Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541125/
https://www.ncbi.nlm.nih.gov/pubmed/34331844
http://dx.doi.org/10.1002/ccd.29889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541125/
https://www.ncbi.nlm.nih.gov/pubmed/34331844
http://dx.doi.org/10.1002/ccd.29889

Ejemplares similares